search
Back to results

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients (FRAGILE)

Primary Purpose

Frail Elderly, Coronary Artery Disease

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Off-pump coronary-artery bypass grafting
On-pump coronary-artery bypass grafting
Sponsored by
University of Sao Paulo General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Frail Elderly focused on measuring Frail elderly, Coronary artery bypass surgery, Off-pump, On-pump, Randomized controlled trial

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

- Participants aged ≥60 years with the indication of myocardial revascularization with ≥2 criteria of frailty by Fried Frailty Criteria, and suitable to undergo either Off-pump or On-pump CABG.

Exclusion criteria:

- Patients with the indication of angioplasty or another procedure in addition to CABG; patients who underwent an emergency operation (within 24 hours after hospital admission); patients who underwent previous cardiac surgery, even with other approaches than median sternotomy; patients who do not have free, prior and informed consent to participate in this study.

Sites / Locations

  • Mount Sinai Hospital
  • Hospital das Clínicas Samuel LibânioRecruiting
  • Hospital Alberto Urquiza WanderleyRecruiting
  • Pronto Socorro Cardiológico de Pernambuco
  • Hospital Samaritano CampinasRecruiting
  • Instituto Nacional de Cardiologia de Laranjeiras
  • Hospital Samaritano PaulistaRecruiting
  • Beneficência Portuguesa de São PauloRecruiting
  • Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São PauloRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Off-pump coronary-artery bypass grafting - OPCAB

On-pump coronary-artery bypass grafting - CABG

Arm Description

Pre-frail and frail patients will be randomly assigned to OPCAB after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the "intervention" section and the patients will be followed up for two years.

Pre-frail and frail patients will be randomly assigned to CABG after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the "intervention" section and the patients will be followed up for two years.

Outcomes

Primary Outcome Measures

Major adverse cardiac and cerebrovascular events after OPCAB and CABG in pre-frail and frail patients
This composite outcome comprises: all cause death, acute myocardial infarction, stroke, renal failure, acute respiratory distress syndrome and bleeding reoperation.

Secondary Outcome Measures

Operative time
Operative time in minutes.
Mechanical ventilation time
Mechanical ventilation time in hours.
Hyperdynamic shock
A cluster of symptoms that signals the onset of septic shock, often including a shaking chill, rapid rise in temperature, flushing of the skin, galloping pulse, and alternating rise and fall of the blood pressure.
New onset of atrial fibrillation
12-lead electrocardiography (ECG) to confirm the diagnosis of new onset atrial fibrillation.
Need for pacing >24 hours
Patient who requires pacing >24 hours.
Renal replacement therapy
Any type of renal replacement therapy in a patient who does not make continued use of this.
Reoperation for bleeding
Patient has to underwent a re-thoracotomy for bleeding arising from a previous surgery.
Pneumonia
Physician or advanced practitioner documents the diagnosis in the medical record based on laboratory findings (e.g. positive sputum culture results from transtracheal fluid and/or bronchial washings) and/or radiological evidence (e.g. chest radiograph diagnostic of pulmonary infiltrates).
Length of stay in intensive care unit
Total time in hours in Intensive Care Unit.
Length of stay in hospital
Total time in days in hospital.
Transfusion requirement
Number of units of blood transfused.
Graft patency
Patency of grafts and coronary artery disease at 6 months of follow-up evaluated by angiotomography.
Clinical and angiographic scores correlation with prognostic
To evaluate the clinical correlation between the revascularization strategy and the usefulness of the SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery score (SYNTAX score); age, creatinine and ejection fraction score (ACEF score); clinical SYNTAX score; European System for Cardiac Operative Risk Evaluation (EuroSCORE II); The Society of Thoracic Surgeon´s risk model (STS score) and Índice de Predição do INStituto do CORação (InsCor) for prognostic evaluation.
Recurrence of angina
To analyse patient recurrence of angina according to the Canadian Cardiovascular Society (CCS).
Rate of complete revascularization
To evaluate and compare the rate of complete revascularization in each one of both strategies.

Full Information

First Posted
August 29, 2014
Last Updated
February 2, 2021
Sponsor
University of Sao Paulo General Hospital
Collaborators
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo, Hospital Alberto Urquiza Wanderley, Hospital das Clínicas Samuel Libânio, Hospital Samaritano Paulista, Beneficência Portuguesa de São Paulo, Hospital Samaritano Campinas, Instituto Nacional de Cardiologia de Laranjeiras, Pronto-Socorro Cardiológico Universitário de Pernambuco, Mount Sinai Hospital, New York
search

1. Study Identification

Unique Protocol Identification Number
NCT02338947
Brief Title
Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients
Acronym
FRAGILE
Official Title
A Multicenter, Prospective, Randomized, Clinical Trial Comparing Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
July 31, 2021 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Sao Paulo General Hospital
Collaborators
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo, Hospital Alberto Urquiza Wanderley, Hospital das Clínicas Samuel Libânio, Hospital Samaritano Paulista, Beneficência Portuguesa de São Paulo, Hospital Samaritano Campinas, Instituto Nacional de Cardiologia de Laranjeiras, Pronto-Socorro Cardiológico Universitário de Pernambuco, Mount Sinai Hospital, New York

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Frailty is defined as a geriatric syndrome of impaired resiliency to stressors (such as cardiac surgery) that has been delineated recently in the cardiovascular literature. One of the most controversial areas of cardiac surgery has been whether off-pump coronary artery bypass grafting (OPCAB) surgery is superior to conventional on-pump coronary artery bypass grafting (CABG) surgery. There is an ongoing debate about the benefits and disadvantages of OPCAB surgery and we believe that this remains an important technique for the improvement of coronary surgery. The benefits of CABG surgery in frail patients are still undetermined. The aim of this study is to clarify the potential benefit of OPCAB surgery in pre-frail and frail patients by comparing off-pump versus on-pump CABG in these patients.
Detailed Description
The FRAGILE protocol is a national multicenter randomized controlled trial (RCT), conducted in 8 Brazilian institutions. The study is already approved by a certified ethics committee. Funding is provided by a grant from São Paulo Research Foundation (FAPESP), which otherwise will not have any role in the conduct of the study nor in the analysis nor in the reporting of data. A confidentiality agreement regarding data use and the data safety will be monitored by an independent monitoring board. All the authors will provide revisions and comments and be testifying for the accuracy and completeness of the report, as well as for the fidelity of the report to the study protocol.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frail Elderly, Coronary Artery Disease
Keywords
Frail elderly, Coronary artery bypass surgery, Off-pump, On-pump, Randomized controlled trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Eligible patients will be randomly assigned to off-pump CABG or on-pump CABG procedure.
Masking
ParticipantOutcomes Assessor
Masking Description
Treatment assignments will be performed in a blinded manner according to a blocked randomization scheme with a block size of ten, stratified according to the participating center.
Allocation
Randomized
Enrollment
630 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Off-pump coronary-artery bypass grafting - OPCAB
Arm Type
Active Comparator
Arm Description
Pre-frail and frail patients will be randomly assigned to OPCAB after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the "intervention" section and the patients will be followed up for two years.
Arm Title
On-pump coronary-artery bypass grafting - CABG
Arm Type
Active Comparator
Arm Description
Pre-frail and frail patients will be randomly assigned to CABG after the evaluation of the target vessels by an internet-based, password protected database program. The surgery will be performed as described in the "intervention" section and the patients will be followed up for two years.
Intervention Type
Procedure
Intervention Name(s)
Off-pump coronary-artery bypass grafting
Other Intervention Name(s)
OPCAB
Intervention Description
Surgical access to the heart will be gained through a median sternotomy in all of the patients. In order to reduce the risk of bleeding and transfusions, an absorbable hemostat will be used in the sternal bone marrow. An automatic autotransfusion system will be used to recovery of red blood cells in all patients. Off-pump surgery will be performed with the use of heart stabilizers. Patients will be heparinized with 250 IU/kg intravenously to achieve activated clotting time >200s. The proximal anastomosis will be performed according to our guidelines. The distal anastomosis will be constructed with the help of mechanical stabilizers and cardiac positioner. Intracoronary shunts will be used routinely.
Intervention Type
Procedure
Intervention Name(s)
On-pump coronary-artery bypass grafting
Other Intervention Name(s)
CABG
Intervention Description
Surgical access to the heart will be gained through a median sternotomy in all of the patients. On-pump surgery will be performed in normothermia, with the use of aortic cross-clamping and cold cardioplegic arrest. Patients will be heparinized with 500 IU/kg to achieve an activated clotting time >480 s. Heparin will be neutralized with 1:1 protamine sulfate. The automatic autotransfusion system will be used just in massive blood loss to recovery the red blood cells. Surgical techniques will be performed according to our guidelines.
Primary Outcome Measure Information:
Title
Major adverse cardiac and cerebrovascular events after OPCAB and CABG in pre-frail and frail patients
Description
This composite outcome comprises: all cause death, acute myocardial infarction, stroke, renal failure, acute respiratory distress syndrome and bleeding reoperation.
Time Frame
30 days, 6 months, 1 and 2 years
Secondary Outcome Measure Information:
Title
Operative time
Description
Operative time in minutes.
Time Frame
30 days
Title
Mechanical ventilation time
Description
Mechanical ventilation time in hours.
Time Frame
30 days
Title
Hyperdynamic shock
Description
A cluster of symptoms that signals the onset of septic shock, often including a shaking chill, rapid rise in temperature, flushing of the skin, galloping pulse, and alternating rise and fall of the blood pressure.
Time Frame
30 days
Title
New onset of atrial fibrillation
Description
12-lead electrocardiography (ECG) to confirm the diagnosis of new onset atrial fibrillation.
Time Frame
30 days
Title
Need for pacing >24 hours
Description
Patient who requires pacing >24 hours.
Time Frame
30 days, 6 months
Title
Renal replacement therapy
Description
Any type of renal replacement therapy in a patient who does not make continued use of this.
Time Frame
30 days, 6 months
Title
Reoperation for bleeding
Description
Patient has to underwent a re-thoracotomy for bleeding arising from a previous surgery.
Time Frame
30 days
Title
Pneumonia
Description
Physician or advanced practitioner documents the diagnosis in the medical record based on laboratory findings (e.g. positive sputum culture results from transtracheal fluid and/or bronchial washings) and/or radiological evidence (e.g. chest radiograph diagnostic of pulmonary infiltrates).
Time Frame
30 days, 6 months
Title
Length of stay in intensive care unit
Description
Total time in hours in Intensive Care Unit.
Time Frame
30 days, 6 months
Title
Length of stay in hospital
Description
Total time in days in hospital.
Time Frame
30 days, 6 months
Title
Transfusion requirement
Description
Number of units of blood transfused.
Time Frame
30 days
Title
Graft patency
Description
Patency of grafts and coronary artery disease at 6 months of follow-up evaluated by angiotomography.
Time Frame
6 months
Title
Clinical and angiographic scores correlation with prognostic
Description
To evaluate the clinical correlation between the revascularization strategy and the usefulness of the SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery score (SYNTAX score); age, creatinine and ejection fraction score (ACEF score); clinical SYNTAX score; European System for Cardiac Operative Risk Evaluation (EuroSCORE II); The Society of Thoracic Surgeon´s risk model (STS score) and Índice de Predição do INStituto do CORação (InsCor) for prognostic evaluation.
Time Frame
1 year
Title
Recurrence of angina
Description
To analyse patient recurrence of angina according to the Canadian Cardiovascular Society (CCS).
Time Frame
30 days, 6 months, 1 and 2 years
Title
Rate of complete revascularization
Description
To evaluate and compare the rate of complete revascularization in each one of both strategies.
Time Frame
30 days
Other Pre-specified Outcome Measures:
Title
Neurobehavioral outcomes after cardiac surgery
Description
To evaluate the global cognitive status a examination test will be performed included 30 simple questions and tasks in a number of areas (orientation in time and place, repeating and recalling list of words, arithmetic, language use and comprehension, non-verbal memory).
Time Frame
6 months, 1 year
Title
Quality of life after cardiac surgery
Description
To evaluate the quality of life by the EuroQol-registration, a five domain and a visual analogue scale (VAS). The best state they can imagine is marked by 100 and the worst state marked by 0.
Time Frame
6 months, 1 year
Title
Cost
Description
The adjusted amount in US dollars of the total cost of coronary artery bypass surgery for all participating hospitals will be evaluated.
Time Frame
2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: - Participants aged ≥60 years with the indication of myocardial revascularization with ≥2 criteria of frailty by Fried Frailty Criteria, and suitable to undergo either Off-pump or On-pump CABG. Exclusion criteria: - Patients with the indication of angioplasty or another procedure in addition to CABG; patients who underwent an emergency operation (within 24 hours after hospital admission); patients who underwent previous cardiac surgery, even with other approaches than median sternotomy; patients who do not have free, prior and informed consent to participate in this study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Omar AV Mejia, MD, PhD
Phone
55(11) 996862043
Email
omar.mejia@incor.usp.br
First Name & Middle Initial & Last Name or Official Title & Degree
Bianca C Meneghini, PhD
Phone
55(11) 26615000
Ext
5432
Email
bianca.meneghini@incor.usp.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Omar AV Mejia, MD, PhD
Organizational Affiliation
InCor Heart Institute
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Fábio B Jatene, MD, PhD
Organizational Affiliation
InCor Heart Institute
Official's Role
Study Chair
Facility Information:
Facility Name
Mount Sinai Hospital
City
New York
State/Province
New York
ZIP/Postal Code
10029-6574
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Hospital das Clínicas Samuel Libânio
City
Pouso Alegre
State/Province
Minas Gerais
ZIP/Postal Code
37550-000
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alexandre C Hueb, MD, PhD
Phone
55(11) 999901932
Email
hueb@uol.com.br
First Name & Middle Initial & Last Name & Degree
Natali Rodrigues, MD
First Name & Middle Initial & Last Name & Degree
Mauricio LJ Guerrieri, MD
First Name & Middle Initial & Last Name & Degree
Alexandre C Hueb, MD, PhD
Facility Name
Hospital Alberto Urquiza Wanderley
City
João Pessoa
State/Province
Paraiba
ZIP/Postal Code
58040-300
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Maurilio O Deininger, MD, PhD
Phone
55(83) 99816776
Email
maurilio.od@gmail.com
First Name & Middle Initial & Last Name & Degree
Eugenia G Deininger, MD, PhD
Phone
55(83) 91219127
Email
eugenia.giuseppe@gmail.com
First Name & Middle Initial & Last Name & Degree
Eugenia G Deininger, MD, PhD
First Name & Middle Initial & Last Name & Degree
Maurilio O Deininger, MD, PhD
Facility Name
Pronto Socorro Cardiológico de Pernambuco
City
Recife
State/Province
Pernambuco
ZIP/Postal Code
50100-010
Country
Brazil
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michel PB de Oliveira Sá, MD, PhD
Phone
+55 81 9773-3190
Email
michel_pompeu@yahoo.com.br
First Name & Middle Initial & Last Name & Degree
Ricardo C Lima, MD, PhD
First Name & Middle Initial & Last Name & Degree
Michel Pompeu BO Sá, MD, MSc, PhD
Facility Name
Hospital Samaritano Campinas
City
Campinas
State/Province
SP
ZIP/Postal Code
13041-304
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gustavo AR Calado, MD, PhD
Phone
11999970275
Email
gcaribeiro@yahoo.com.br
First Name & Middle Initial & Last Name & Degree
Mauricio M Lopes, MD, PhD
First Name & Middle Initial & Last Name & Degree
Jean MP Oliveira, MD
First Name & Middle Initial & Last Name & Degree
Gustavo AR Calado, MD, PhD
Facility Name
Instituto Nacional de Cardiologia de Laranjeiras
City
Rio De Janeiro
ZIP/Postal Code
22240-002
Country
Brazil
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rodrigo C Segalote, MD, PhD
Phone
55 21 98275-2828
Email
rsegalote@gmail.com
First Name & Middle Initial & Last Name & Degree
Rodrigo C Segalote, MD, PhD
First Name & Middle Initial & Last Name & Degree
Felipe Cosentino, MD
Facility Name
Hospital Samaritano Paulista
City
São Paulo
ZIP/Postal Code
01317-002
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Omar AV Mejia, MD, PhD
Phone
55(11) 996862043
Email
omar.mejia@incor.usp.br
First Name & Middle Initial & Last Name & Degree
Pedro MB Silva, MD
First Name & Middle Initial & Last Name & Degree
Omar AV Mejia, MD, PhD
Facility Name
Beneficência Portuguesa de São Paulo
City
São Paulo
ZIP/Postal Code
01323-001
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marco AP Oliveira, MD, PhD
Phone
(55)11 999896032
Email
marcoapoliveira@uol.com.br
First Name & Middle Initial & Last Name & Degree
Fernando F Ribas, MD
First Name & Middle Initial & Last Name & Degree
Marco AP Oliveira, MD, PhD
Facility Name
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo
City
São Paulo
ZIP/Postal Code
05403-900
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Omar AV Mejia, MD, PhD
Phone
55(11) 996862043
Email
omar.mejia@incor.usp.br
First Name & Middle Initial & Last Name & Degree
Bianca C Meneghini, PhD
Phone
55(11) 999970275
Email
bianca.meneghini@incor.usp.br
First Name & Middle Initial & Last Name & Degree
Luís AO Dallan, MD, PhD
First Name & Middle Initial & Last Name & Degree
Luiz AF Lisboa, MD, PhD
First Name & Middle Initial & Last Name & Degree
Bruno M Mioto, MD, PhD
First Name & Middle Initial & Last Name & Degree
Cibele L Garzillo, MD, PhD
First Name & Middle Initial & Last Name & Degree
Carlos V Serrano Junior, MD, PhD
First Name & Middle Initial & Last Name & Degree
Filomena RG Galas, MD, PhD
First Name & Middle Initial & Last Name & Degree
José C Nicolau, MD, PhD
First Name & Middle Initial & Last Name & Degree
Luiz AM César, MD, PhD
First Name & Middle Initial & Last Name & Degree
Solange Andrade, MD, PhD
First Name & Middle Initial & Last Name & Degree
Bianca C Meneghini, PhD
First Name & Middle Initial & Last Name & Degree
Roberto Kalil Filho, MD, PhD
First Name & Middle Initial & Last Name & Degree
Fabio B Jatene, MD, PHD
First Name & Middle Initial & Last Name & Degree
Omar AV Mejia, MD, PHD

12. IPD Sharing Statement

Citations:
PubMed Identifier
29211225
Citation
Mejia OAV, Sa MPBO, Deininger MO, Dallan LRP, Segalote RC, Oliveira MAP, Atik FA, Santos MAD, Silva PGMBE, Milani RM, Hueb AC, Monteiro R, Lima RC, Lisboa LAF, Dallan LAO, Puskas J, Jatene FB. Off-pump versus On-pump Coronary Artery Bypass Grafting in Frail Patients: Study Protocol for the FRAGILE Multicenter Randomized Controlled Trial. Braz J Cardiovasc Surg. 2017 Sep-Oct;32(5):428-434. doi: 10.21470/1678-9741-2017-0196.
Results Reference
derived
Links:
URL
http://www.fapesp.br/en
Description
São Paulo Research Foundation
URL
http://www.zerbini.org.br
Description
Zerbini Foundation
URL
http://www.sbccv.org.br
Description
Brazilian Cardiovascular Society

Learn more about this trial

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

We'll reach out to this number within 24 hrs